Abstract: An electronic platform to measure a maturity or level of an entity in view of regulatory and business risks relating to regulatory compliance. The methods and systems can collect various data (e.g., regulatory agency reports, regulatory agency warning letters (e.g. FDA warning letters), internal and vendor company audit results, fines and settlement information, country business risks, regulatory agency product recalls, etc.) from various different data sources. The collected information is analyzed using machine learning techniques to determine a risk compliance level or score for one or more of an entity's companies, functions, control types, and locations arising from regulatory audit non-conformances. The risk compliance scores can be used to generate a risk prediction and identify one or more actions to be taken by the entity to improve or increase an associated compliance level.

Abstract: An electronic platform to measure a maturity or level of an entity in view of regulatory and business risks relating to regulatory compliance. The methods and systems can collect various data (e.g., regulatory agency reports, regulatory agency warning letters (e.g. FDA warning letters), internal and vendor company audit results, fines and settlement information, country business risks, regulatory agency product recalls, etc.) from various different data sources. The collected information is analyzed using machine learning techniques to determine a risk compliance level or score for one or more of an entity's companies, functions, control types, and locations arising from regulatory audit non-conformances. The risk compliance scores can be used to generate a risk prediction and identify one or more actions to be taken by the entity to improve or increase an associated compliance level.

Abstract: A system and method for enhancing productivity of sales and marketing operations of pharmaceutical companies is provided. The method includes collecting information pertaining to pharmaceutical sales and marketing operations from all available sources. The method further includes processing the collected information to identify a plurality of market segments, to determine performance of sales representatives, and to determine impact of sales and marketing efforts. Further, the method includes generating marketing content based on the processed information. Marketing content is generated based on feedback on previous sales and marketing materials, specific questions asked during sales interactions and new research on pharmaceutical medicines. Ultimately, pharmaceutical sales and marketing campaigns are generated based on the generated marketing content.